相关实验视频

Updated: Jul 16, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

开发ACE-III性能有效性测试,用于痴呆症查

Donnchadh Murphy¹, Rupert Noad²

¹Peninsula Medical School, University of Plymouth, Plymouth, UK.

Journal of clinical and experimental neuropsychology

|March 2, 2026

概括

嵌入在ACE-III中的新性能有效性测试 (PVTs) 显示出对痴呆症查的希望. 对象识别和ACE-III数字跨度测试在临床环境中有效地区分真实的认知障碍和模拟的认知障碍.

科学领域:

神经心理学神经心理学
认知科学认知科学
老年学是一门学科.

背景情况:

性能验证测试 (PVT) 在神经心理评估中至关重要.
需要简短的,经过验证的PVT,与痴呆症查工具兼容.
阿登布鲁克的认知检查-III (ACE-III) 是一种常见的认知查评估.

研究的目的:

开发和评估简短的PVT,并纳入ACE-III.
评估这些PVT在痴呆症诊所环境中的实用性.
确定可靠的措施来检测在查期间的不良认知表现.

主要方法:

一项诊断准确性研究比较了阿尔茨海默氏症痴呆症患者和健康的老年人模拟痴呆症.
参与者完成了ACE-III,Memory Malingering测试 (TOMM) 和五个基于ACE-III的PVT.
新的PVTs包括对象识别测试,词识别测试,点数计数,ACE-III数字跨度和盒子中的硬币测试.

主要成果:

第二个TOMM试验的准确性很高 (AUC=0.92),但对于中度痴呆症患者来说很难完成.
综合物体识别测试 (AUC=0.89) 和ACE-III数字跨度 (AUC=0.85) 显示出高的诊断准确性.
这些ACE-III PVT有效地区分了真正的认知障碍与模拟的认知障碍.

结论:

对象识别测试和ACE-III数字跨度是将其整合到ACE-III的潜在候选者.
在临床推之前,需要对已知组设计进行进一步的研究.
在查背景下,必须考虑非神经心理学家对PVT的管理.

关键词:

这是ACE-III.阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.性能有效性的有效性.痴呆症痴呆症是一种痴呆症.努力测试努力测试努力测试

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...